Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

Tracking CAML sizes throughout CRT as a minimally invasive biomarker may serve as a prognostic tool in mapping EC progression, and further studies are warranted to determine if presence of these cells prior to treatment suggest diagnostic value for at-risk populations.